title: Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
authors.forename: Padmanabhan
authors.initials: P
authors.lastname: Raghu
authors.forename: Paramjeet Singh
authors.initials: PS
authors.lastname: Grover
authors.forename: Ashok
authors.initials: A
authors.lastname: Kumar
mesh_terms: D000284:Administration, Oral; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D008727:Methotrexate / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate